The New Energy Crisis No One Saw Coming
Free investor report reveals how the electric car initiative is putting the U.S. in peril...and shows how to potentially capitalize on this crisis with a junior mining company.
See how this new energy crisis could create a boom
Steven J. Quinlan net worth and biography

Steven Quinlan Biography and Net Worth

CFO of Neogen

Steve has served as NEOGEN’s Chief Financial Officer since 2011, following nine previous years of CFO experience at Detrex Corporation, and 19 total years there. He’s responsible for our internal and external financial reporting, and manages our corporate accounting, treasury, human resources, IT and investor relations groups. He began his career in 1985 on the audit staff at Price Waterhouse (now PWC).

 

What is Steven J. Quinlan's net worth?

The estimated net worth of Steven J. Quinlan is at least $505,227.68 as of October 11th, 2022. Mr. Quinlan owns 32,722 shares of Neogen stock worth more than $505,228 as of December 6th. This net worth approximation does not reflect any other investments that Mr. Quinlan may own. Additionally, Mr. Quinlan receives an annual salary of $602,850.00 as CFO at Neogen. Learn More about Steven J. Quinlan's net worth.

How old is Steven J. Quinlan?

Mr. Quinlan is currently 60 years old. There are 4 older executives and no younger executives at Neogen. Learn More on Steven J. Quinlan's age.

What is Steven J. Quinlan's salary?

As the CFO of Neogen Co., Mr. Quinlan earned a total compensation package of $877,482.00 in 2021. Mr. Quinlan earned a salary of $274,519.00, a bonus of $100,000.00, stock awards of $192,265.00, options awards of $303,882.00, and other compensation of $6,816.00.There are 2 executives that earn more than Mr. Quinlan. The highest earning executive at Neogen is Mr. John Edward Adent, Pres, CEO & Director, who commands a salary of $1,390,000.00 per year. Learn More on Steven J. Quinlan's salary.

How do I contact Steven J. Quinlan?

The corporate mailing address for Mr. Quinlan and other Neogen executives is 620 LESHER PLACE, LANSING MI, 48912. Neogen can also be reached via phone at (517) 372-9200 and via email at [email protected] Learn More on Steven J. Quinlan's contact information.

Has Steven J. Quinlan been buying or selling shares of Neogen?

Over the course of the past ninety days, Steven J. Quinlan has bought $58,150.00 in Neogen stock. Most recently, on Tuesday, October 11th, Steven J. Quinlan bought 5,000 shares of Neogen stock. The stock was acquired at an average cost of $11.63 per share, with a total value of $58,150.00. Following the completion of the transaction, the chief financial officer now directly owns 32,722 shares of the company's stock, valued at $380,556.86. Learn More on Steven J. Quinlan's trading history.

Who are Neogen's active insiders?

Neogen's insider roster includes William Boehm (Director), Douglas Jones (Insider), Jason Lilly (VP), Terri Morrical (Director), G. Papesh (Director), Steven Quinlan (CFO), and James Tobin (Director). Learn More on Neogen's active insiders.

Are insiders buying or selling shares of Neogen?

In the last twelve months, Neogen insiders bought shares 9 times. They purchased a total of 59,500 shares worth more than $1,059,760.00. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 3,636 shares worth more than $148,562.76. The most recent insider tranaction occured on October, 11th when CFO Steven J Quinlan bought 5,000 shares worth more than $58,150.00. Insiders at Neogen own 0.7 % of the company. Learn More about insider trades at Neogen.

Information on this page was last updated on 10/11/2022.

Steven J. Quinlan Insider Trading History at Neogen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/11/2022Buy5,000$11.63$58,150.0032,722View SEC Filing Icon  
9/29/2021Sell5,700$44.05$251,085.00View SEC Filing Icon  
4/14/2021Sell13,001$93.93$1,221,183.9326,471View SEC Filing Icon  
1/7/2021Sell9,333$84.49$788,545.1722,803View SEC Filing Icon  
1/14/2020Sell8,031$69.65$559,359.1521,501View SEC Filing Icon  
10/15/2019Sell4,801$65.00$312,065.0018,271View SEC Filing Icon  
7/25/2019Sell15,000$69.04$1,035,600.0028,470View SEC Filing Icon  
5/1/2019Sell6,902$60.13$415,017.2620,372View SEC Filing Icon  
2/19/2019Sell4,800$62.50$300,000.00View SEC Filing Icon  
8/30/2018Sell3,600$89.08$320,688.0017,070View SEC Filing Icon  
7/23/2018Sell3,802$82.01$311,802.0217,272View SEC Filing Icon  
5/7/2018Sell5,000$71.82$359,100.0018,470View SEC Filing Icon  
3/27/2018Sell5,000$66.13$330,650.0015,203View SEC Filing Icon  
2/21/2018Sell2,000$60.15$120,300.0015,470View SEC Filing Icon  
10/31/2017Sell4,000$80.26$321,040.0014,103View SEC Filing Icon  
10/4/2017Sell2,250$78.52$176,670.00View SEC Filing Icon  
9/25/2017Sell2,772$73.54$203,852.8812,875View SEC Filing Icon  
8/8/2017Sell4,000$68.68$274,720.0014,103View SEC Filing Icon  
4/27/2017Sell2,676$63.68$170,407.6812,779View SEC Filing Icon  
1/4/2017Sell5,352$66.13$353,927.7615,455View SEC Filing Icon  
11/14/2016Sell3,000$61.28$183,840.0013,103View SEC Filing Icon  
9/30/2016Sell3,000$55.15$165,450.0013,103View SEC Filing Icon  
3/24/2016Buy2,236$44.73$100,016.2810,103View SEC Filing Icon  
9/22/2015Buy1,060$47.17$50,000.207,867View SEC Filing Icon  
7/22/2015Sell4,500$59.76$268,920.00View SEC Filing Icon  
2/19/2015Sell1,500$48.70$73,050.00View SEC Filing Icon  
See Full Table

Steven J. Quinlan Buying and Selling Activity at Neogen

This chart shows Steven J Quinlan's buying and selling at Neogen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neogen Company Overview

Neogen logo
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Read More

Today's Range

Now: $15.44
Low: $15.31
High: $15.83

50 Day Range

MA: $13.97
Low: $10.79
High: $16.56

2 Week Range

Now: $15.44
Low: $10.49
High: $47.80

Volume

120,781 shs

Average Volume

3,457,695 shs

Market Capitalization

$1.67 billion

P/E Ratio

45.41

Dividend Yield

N/A

Beta

0.78
The New Energy Crisis No One Saw Coming
Free investor report reveals how the electric car initiative is putting the U.S. in peril...and shows how to potentially capitalize on this crisis with a junior mining company.
See how this new energy crisis could create a boom